Toxicology - OPEN Foundation

Key interindividual determinants in MDMA pharmacodynamics

Papaseit, E., Torrens, M., Pérez-Mañá, C., Muga, R., & Farré, M. | Expert opinion on drug metabolism & toxicology | 14 February 2018

Evaluating the abuse potential of psychedelic drugs for medical use in humans

Heal, D. J., Gosden, J., & Smith, S. L. | Neuropharmacology | 7 February 2018

Is LSD toxic?

Nichols, D. E., & Grob, C. S. | Forensic science international | 2 February 2018

Psychedelic Drugs in Biomedicine

Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. | Trends in Pharmacological Sciences | 22 September 2017

MDA, MDMA and other mescaline-like substances in the US military’s search for a truth drug (1940s to 1960s)

Passie, T., & Benzenhöfer, U. | Drug testing and analysis | 29 August 2017

Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs

Hassan, Z., Bosch, O. G., Singh, D., Narayanan, S., Kasinather, B. V., Seifritz, E., ... & Müller, C. P. | Frontiers in psychiatry | 18 August 2017

Mushroom-Derived Indole Alkaloids

Homer, J. A., & Sperry, J. | Journal of Natural Products | 19 July 2017

First time view on human metabolome changes after a single intake of 3,4 methylenedioxymethamphetamine (MDMA) in healthy placebo-controlled subjects

Boxler, M. I., Liechti, M. E., Schmid, Y., Kraemer, T., & Steuer, A. E. | Journal of Proteome Research | 19 July 2017

Isolated non-cardiogenic pulmonary edema – A rare complication of MDMA toxicity

Haaland, A., Warman, E., Pushkar, I., Likourezos, A., & Friedman, M. S. | The American journal of emergency medicine | 27 June 2017

A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum

Li, S., Cheng, X., & Wang, C. | Journal of Ethnopharmacology | 5 May 2017

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

Brown, R. T., Nicholas, C. R., Cozzi, N. V., Gassman, M. C., Cooper, K. M., Muller, D., ... & Hutson, P. R. | Clinical Pharmacokinetics | 28 March 2017

LSD instead of 25I-NBOMe: The revival of LSD? A case report

Bodeau, S., Bennis, Y., Régnaut, O., Fabresse, N., Richeval, C., Humbert, L., ... & Lemaire-Hurtel, A. S. | Toxicologie Analytique et Clinique | 27 February 2017

Toxicokinetics of ibogaine and noribogaine in a patient with prolonged multiple cardiac arrhythmias after ingestion of internet purchased ibogaine

Henstra, M., Wong, L., Chahbouni, A., Swart, N., Allaart, C., & Sombogaard, F. | Clinical Toxicology | 9 February 2017

Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance

Dinis-Oliveira, R. J. | Drug Metabolism Reviews | 31 January 2017

Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects

Vizeli, P., Schmid, Y., Prestin, K., zu Schwabedissen, H. E. M., & Liechti, M. E. | European Neuropsychopharmacology | 20 January 2017

Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens

Halberstadt, A. L. | Current Topics in Behavioral Neurosciences | 18 January 2017

Hyperthermia Severely Affects the Vascular Effects of MDMA and Metabolites in the Human Internal Mammary Artery In Vitro

Fonseca, D. A., Guerra, A. F., Carvalho, F., Fernandes, E., Ferreira, L. M., Branco, P. S., ... & Cotrim, M. D. | Cardiovascular Toxicology | 13 January 2017

Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015

Heise, C. W., & Brooks, D. E. | Journal of medical toxicology | 28 November 2016

A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4 Methylendioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction

Darracq, M. A., Thornton, S. L., Minns, A. B., & Gerona, R. R. | Journal of Psychoactive Drugs | 16 September 2016